Tharlow: “Pi-88 merely manages the symptoms, whereas there are...

Tharlow: “Pi-88 merely manages the symptoms, whereas there are multiple drugs being trialled that solve the problems at source. The drug, even if it gets to market, will have a shelf life of 6 months at best.”

Tharlow, you are not being specific.

Please name the “drugs being trialed” – can you provide details of which drugs, company names, pre-clinical or clinical and in which phase they are currently being tested.

Tharlow: “The market is starting to recognise this, and a re-rating is in progress. This wave of selling is just the beginning.”

You are very very wrong and time will prove how costly that will be for you.